Drug name - Lamictal Odt

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7919115 GLAXOSMITHKLINE LLC Orally disintegrating tablet compositions of lamotrigine
Jan, 2029

(6 years from now)

CN101801192B GLAXOSMITHKLINE LLC Orally Disintegrating Tablet Compositions Of Lamotrigine
Jul, 2028

(5 years from now)

CN101801192A GLAXOSMITHKLINE LLC Lamotrigine And Oral Administration Disintegrating Tablet Composition
Jul, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8840925 GLAXOSMITHKLINE LLC Orally disintegrating tablet compositions of lamotrigine Jul, 2028

(5 years from now)

US9339504 GLAXOSMITHKLINE LLC Orally disintegrating tablet compositions of lamotrigine Jul, 2028

(5 years from now)

Drugs and Companies using LAMOTRIGINE ingredient

Treatment: Lamictal is an antiepileptic drug (aed) indicated for: epilepsy-adjunctive therapy in patients greater than or equal to 2 years of age: (1.1) partial seizures primary generalized tonic-clonic seizures

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage
Strength Dosage Availability
25MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription
50MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription
100MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription
200MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.